These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 8515745

  • 21. [Production of the trypsin-activable toxin by Clostridium botulinum type C and D strains (author's transl)].
    Nakane A.
    Nihon Saikingaku Zasshi; 1977 Nov; 32(6):805-11. PubMed ID: 342740
    [No Abstract] [Full Text] [Related]

  • 22. Adsorption of Clostridium botulinum cultures of phage controlling type C botulinum toxin production.
    Oguma K, Iida H, Sugiyama H.
    Jpn J Med Sci Biol; 1979 Apr; 32(2):125-6. PubMed ID: 396393
    [No Abstract] [Full Text] [Related]

  • 23. Molecular investigation of genetic elements contributing to metronidazole resistance in Bacteroides strains.
    Sóki J, Gal M, Brazier JS, Rotimi VO, Urbán E, Nagy E, Duerden BI.
    J Antimicrob Chemother; 2006 Feb; 57(2):212-20. PubMed ID: 16338949
    [Abstract] [Full Text] [Related]

  • 24. Serological studies of Clostridium botulinum type E and related organisms. II. Serology of spores.
    Solomon HM, Lynt RK, Kautter DA, Lilly T.
    J Bacteriol; 1969 May; 98(2):407-14. PubMed ID: 4891254
    [Abstract] [Full Text] [Related]

  • 25. Plasmid localization of a type E botulinal neurotoxin gene homologue in toxigenic Clostridium butyricum strains, and absence of this gene in non-toxigenic C. butyricum strains.
    Hauser D, Gibert M, Boquet P, Popoff MR.
    FEMS Microbiol Lett; 1992 Dec 01; 78(2-3):251-5. PubMed ID: 1490606
    [Abstract] [Full Text] [Related]

  • 26. Quantitative detection of gene expression and toxin complex produced by Clostridium botulinum serotype D strain 4947.
    Kouguchi H, Suzuki T, Hasegawa K, Mutoh S, Watanabe T, Niwa K, Yoneyama T, Katoh Y, Ohyama T.
    J Microbiol Methods; 2006 Dec 01; 67(3):416-23. PubMed ID: 16725219
    [Abstract] [Full Text] [Related]

  • 27. Cloning of a DNA sequence unique to Clostridium botulinum group I by selective hybridization.
    McKinney MW, Levett PN, Haylock RW.
    J Clin Microbiol; 1993 Jul 01; 31(7):1845-9. PubMed ID: 8349762
    [Abstract] [Full Text] [Related]

  • 28. Competitive inhibition between different Clostridium botulinum types and strains.
    Eklund MW, Poysky FT, Peterson ME, Paranjpye RN, Pelroy GA.
    J Food Prot; 2004 Dec 01; 67(12):2682-7. PubMed ID: 15633672
    [Abstract] [Full Text] [Related]

  • 29. Isolation of nontoxigenic variants associated with enhanced sporulation and alteration in the cell wall from Clostridium botulinum type a 190L by treatment with detergents.
    Takumi K, Kinouchi T, Kawata T.
    Microbiol Immunol; 1980 Dec 01; 24(6):469-77. PubMed ID: 6997693
    [Abstract] [Full Text] [Related]

  • 30. [Clostridium botulinum in Costa Rica soils].
    Gamboa MM, Rodríguez E, Fernández B.
    Rev Biol Trop; 1993 Dec 01; 41(3A):359-63. PubMed ID: 7701075
    [Abstract] [Full Text] [Related]

  • 31. [Clostridium botulinum type C: 1. Selection of a highly toxigenic bacterial population from a pure culture].
    Vinet G, Daigneault N.
    Can J Microbiol; 1976 Sep 01; 22(9):1229-32. PubMed ID: 788871
    [No Abstract] [Full Text] [Related]

  • 32. Differentiation of Clostridium perfringens and Clostridium botulinum from non-toxigenic clostridia, isolated from prepared and frozen foods by PCR-DAN based methods.
    Córdoba MG, Aranda E, Medina LM, Jordano R, Córdoba JJ.
    Nahrung; 2001 Apr 01; 45(2):125-8. PubMed ID: 11379285
    [Abstract] [Full Text] [Related]

  • 33. Isolation and some properties of nontoxigenic derivatives of a strain of Clostridium tetani.
    Hara T, Matsuda M, Yoneda M.
    Biken J; 1977 Dec 01; 20(3-4):105-15. PubMed ID: 352338
    [Abstract] [Full Text] [Related]

  • 34. Real-time PCR detection of the nontoxic nonhemagglutinin gene as a rapid screening method for bacterial isolates harboring the botulinum neurotoxin (A-G) gene complex.
    Raphael BH, Andreadis JD.
    J Microbiol Methods; 2007 Dec 01; 71(3):343-6. PubMed ID: 17961766
    [Abstract] [Full Text] [Related]

  • 35. Development of a transformation and gene reporter system for group II, non-proteolytic Clostridium botulinum type B strains.
    Davis TO, Henderson I, Brehm JK, Minton NP.
    J Mol Microbiol Biotechnol; 2000 Jan 01; 2(1):59-69. PubMed ID: 10937489
    [Abstract] [Full Text] [Related]

  • 36. Effects of mastic resin and its essential oil on the growth of proteolytic Clostridium botulinum.
    Daifas DP, Smith JP, Blanchfield B, Sanders G, Austin JW, Koukoutisis J.
    Int J Food Microbiol; 2004 Aug 01; 94(3):313-22. PubMed ID: 15246242
    [Abstract] [Full Text] [Related]

  • 37. Construction of a nontoxigenic Clostridium botulinum strain for food challenge studies.
    Bradshaw M, Marshall KM, Heap JT, Tepp WH, Minton NP, Johnson EA.
    Appl Environ Microbiol; 2010 Jan 01; 76(2):387-93. PubMed ID: 19933346
    [Abstract] [Full Text] [Related]

  • 38. Growth and toxigenic activities of Clostridium botulinum type A in a molasses medium.
    de Rigo AG, Silva HJ, Segovia R, Ertola R.
    Rev Latinoam Microbiol; 1978 Jan 01; 20(4):219-21. PubMed ID: 388562
    [No Abstract] [Full Text] [Related]

  • 39. Phage conversion to hemagglutinin production in Clostridium botulinum types C and D.
    Oguma K, Iida H, Shiozaki M.
    Infect Immun; 1976 Sep 01; 14(3):597-602. PubMed ID: 786888
    [Abstract] [Full Text] [Related]

  • 40. Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages.
    Eklund MW, Poysky FT.
    Appl Microbiol; 1974 Jan 01; 27(1):251-8. PubMed ID: 4589131
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.